Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Abbisko, Amarin, Ascletis, Astellas, Astrazeneca, Axcella, Beigene, Carina, Daewoong, Daiichi Sankyo, Duality, Eisai, Genexine, Harbour Biomed, Henlius, Hutchmed, Immunos, Immuron, Junshi, Luye, Neuren, Novavax, Paratek, Pfizer, Revive, Sinopharm, Sofie, Specialised, Takeda, Valeo, Yantai LNC.